17/02/2026
Over 200 doctors. One unified vision. The future of cancer careâdecoded.
HCG hosted a landmark Continuing Medical Education (CME) programme in Kolkata titled âDecoding the Future of Cancer Care â Harnessing Next-Generation Intelligence to Transform Patient Outcomes,â led by Dr. B. S. Ajaikumar, Founder and Chairman, HCG.
The high-impact forum brought together leading oncologists and multidisciplinary specialists from across Eastern India with a clear goal: delivering the right treatment, the first timeâthrough precision medicine, genomics, advanced diagnostics, AI-enabled tools, and structured outcomes-driven data systems.
Dr. Ajaikumar emphasized the importance of applying innovation with clinical rigour, supported by disciplined data collection, longitudinal outcome tracking, and multidisciplinary, evidence-based decision-making to improve long-term patient outcomes and reduce recurrence.
Adding to this vision, Dr. Manish Mattoo, CEO & Executive Director, HealthCare Global Enterprises Ltd., highlighted that the future of oncology lies in building systems that consistently enable the right treatment decisions at the right time. He reinforced HCGâs commitment to integrating research, technology, and data into everyday care delivery to enhance predictability, efficiency, and outcomes across the cancer care continuum.
Highlighting the regional relevance, Dr. Rupali Basu, Regional Business Head â East & AP, HCG, noted the evolving cancer trends across Eastern and North-Eastern India and emphasized the importance of strengthening knowledge exchange, clinical collaboration, and future-ready infrastructureâincluding Outreach Centresâto ensure advanced oncology care reaches patients closer to home.
Because the future of cancer care isnât just about innovationâitâs about precision, predictability, and outcomes that truly add life to years.